Similar articles

• [Utilizing progress in modern antihypertensive therapy. Treating hypertension effectively from the beginning].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 May 12;147(19):48. MMW Fortschr Med. 2005. PMID: 15940938 German. No abstract available.
• Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers: a quantitative overview.

  Wang JG, Li Y, Franklin SS, Safar M. Wang JG, et al. Hypertension. 2007 Jul;50(1):181-8. doi: 10.1161/HYPERTENSIONAHA.107.089763. Epub 2007 May 14. Hypertension. 2007. PMID: 17502490
• Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.

  Tempelhof MW. Tempelhof MW. South Med J. 2009 Dec;102(12):1201-2. doi: 10.1097/SMJ.0b013e3181bef7bd. South Med J. 2009. PMID: 20016423 No abstract available.
• Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.

  Talbert RL. Talbert RL. J Am Pharm Assoc (2003). 2010 Sep-Oct;50(5):e116-25. doi: 10.1331/JAPhA.2010.09234. J Am Pharm Assoc (2003). 2010. PMID: 20833609 Review.
• Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.

  Lambers Heerspink HJ. Lambers Heerspink HJ. Contrib Nephrol. 2013;179:7-14. doi: 10.1159/000346717. Epub 2013 May 3. Contrib Nephrol. 2013. PMID: 23652444 Review.